Empowerment, Motivation and Medical Adherence (EMMA). (EMMA)
Type2 Diabetes Mellitus
About this trial
This is an interventional supportive care trial for Type2 Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria:
- Adults with type 2 diabetes ≥ 18 years
- Type 2 diabetes ≥ 1 years
- HbA1c ≥ 8 % at the last three visits before randomization
- On oral or injectable medications (insulin, GLP-1; DPP-4)
- Can speak, read and understand English
Exclusion Criteria:
- Participation in other clinical intervention studies during the trial period
- Receiving psychological or psychiatric treatment for a mental health disorder
- Severely impaired vision or blindness
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
EMMA
Treatment as Usual
These participants will receive diabetes self-management education using the dialogue tools, which emphasize empowerment and use the principles of motivational communication and behaviour modification. There will be a series of four visits using the dialogue tools to guide the patient toward meaningful self-management tasks. This is not the typical approach, where providers tell the patient the behaviours they, not the patient, consider priorities. This intervention will evaluate if medical outcomes (A1c) and adherence are improved using a patient-centered not a clinician-cantered approach in individuals with poor diabetes control.
The participants will receive standard diabetes education via group and individual sessions with certified diabetes educators. In this method the patient is provided structured education in which there is an emphasis on covering clinician-determined aspects of diabetes knowledge and self-management. The emphasis vis on diabetes educator recommendations.